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Differential expression pattern 
of Vago in bumblebee (Bombus 
terrestris), induced by virulent and 
avirulent virus infections
Jinzhi Niu1,2, Ivan Meeus2 & Guy Smagghe1,2
Viruses are one of the main drivers of the decline of domesticated and wild bees but the mechanisms 
of antiviral immunity in pollinators are poorly understood. Recent work has suggested that next to the 
small interfering RNA (siRNA) pathway other immune-related pathways play a role in the defense of 
the bee hosts against viral infection. In addition, Vago plays a role in the cross-talk between the innate 
immune pathways in Culex mosquito cells. Here we describe the Vago orthologue in bumblebees of 
Bombus terrestris, and investigated its role upon the infection of two different bee viruses, the virulent 
Israeli acute paralysis virus (IAPV) and the avirulent slow bee paralysis virus (SBPV). Our results showed 
that BtVago was downregulated upon the infection of IAPV that killed all bumblebees, but not with 
SBPV where the workers survived the virus infection. Thus, for the first time, Vago/Vago-like expression 
appears to be associated with the virulence of virus and may act as a modulator of antiviral immunity.
Insects and other invertebrates lack an adaptive immune system, which indicates that the innate immunity in 
these species is critical to modulate viral infections. Based on the mechanism to tackle virus in insects, the anti-
viral innate immune pathways can be generally grouped into two strategies of either nucleotide-based [as RNA 
interference (RNAi)] or protein-based [as Toll, Immune Deficiency (Imd) and the Janus kinase/signal trans-
ducer and activator of transcription pathway (JAK/STAT)]1,2. The small interfering RNA (siRNA) pathway (i.e., 
sub-pathway of RNAi) is the most prominent example for the nucleotide-based antiviral strategy in insects. 
During viral infection, specifically in RNA viruses, virus-related dsRNAs are generated from viral dsRNA rep-
lication intermediates, the viral genome itself, and/or viral transcriptions3. These virus-related dsRNAs are pro-
cessed into 21~22 nt siRNAs by Dicer, and then these siRNAs are loaded onto Argonaute (Ago) forming the 
RNA-induced silencing complex (RISC) with other proteins4. One of the strands of siRNAs is selected and serves 
as a sequence-specific guide to cleave target viral mRNA (or genome) by complementary binding5. In mammals, 
these virus-derived long dsRNAs generally induce a protein-based innate antiviral immune response called the 
interferon response to control viral infection, which supplants the insect antiviral response of the siRNA path-
way6. As a protein-based innate antiviral immune pathway, JAK/STAT has also been reported to combat various 
viruses in insects7–9. This pathway was discovered from the role of interferon in the control of immune response 
in vertebrates, and is now recognized to play a very important role in the regulation of both innate immune and 
adaptive immune systems10,11. In insects, the JAK/STAT pathway is generally initiated by the ligand unpaired 
(Upd) binding to the transmembrane receptor Domeless (Dome) which is a distant homolog of the vertebrate 
type I cytokine. The conformational change of Dome after Upd binding leads to the self-phosphorylation of the 
Janus kinase Hopscotch (Hop); however, the homologue of Upd was not identified in bees12,13. The activated 
Hop phosphorylates Dome, thereby forming docking sites for the cytoplasmic STATs. The recruitment of STAT 
by these docking sites enables Hop to phosphorylate STAT which leads to its dimerization. Subsequently, the 
STAT dimers translocate to the nucleus where they activate transcription of specific effectors to control viruses14. 
Intriguingly, the siRNA pathway communicates with the JAK/STAT pathway during viral infection in mosquito 
cells through Vago7,15,16. Briefly, upon viral infection, the upregulation of Dicer-2 of the siRNA pathway leads to 
1Key Laboratory of Entomology and Pest Control Engineering, College of Plant Protection, Southwest University, 
Chongqing 400716, China. 2Department of Crop Protection, Faculty of Bioscience Engineering, Ghent University, 
Coupure Links 653, B-9000 Ghent, Belgium. Correspondence and requests for materials should be addressed to G.S. 
(email: guy.smagghe@ugent.be)
received: 11 January 2016
accepted: 06 September 2016
Published: 29 September 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:34200 | DOI: 10.1038/srep34200
the activation of Vago transcription, which increases the level of secreted Vago. Subsequently, Vago induces the 
JAK/STAT antiviral immunity in a manner which is similar to mammalian interferon7,15. However, the role of 
Vago in other insects during viral infections is rarely known7,15,17.
Viruses, being often transmitted between domesticated and wild bees18–21, are proven to be one of the drivers 
of bee colony declines22,23. Bee viruses are mainly from the families of Dicistroviridae and Iflaviridae in the order 
of Picornavirales, which are non-enveloped small icosahedral virions, covering a positive sense single stranded 
RNA genome. In wild bumblebees, Israeli acute paralysis virus (IAPV) from Dicistroviridae and slow bee paraly-
sis virus (SBPV) from Iflaviridae have been detected18–21, but symptoms of infection have not yet been reported. 
In our previous study24, IAPV replicates very fast and acts as a very virulent virus in bumblebees while SBPV 
also replicates fast but induces no mortality after injection. Furthermore, both IAPV and SBPV infections could 
induce the expression of Dicer-2 in B. terrestris. IAPV but not SBPV infection triggered the production of pre-
dominantly 22 nt-long virus-derived siRNAs. However, the silencing of Dicer-2 by RNAi did not result in an 
altered genome copy number of IAPV and SBPV24. In both honeybees and bumblebees, non-specific dsRNA can 
also induce a noticeable antiviral activity25,26. Indeed in honeybee, genes from immune pathways like RNAi, Toll 
and JAK/STAT, showed different expressions upon bee viral infections27. Thus, it is speculated that other immune 
pathways could be important in the control of viral infections. Here we suggest that the antiviral response in 
bumblebees goes beyond the siRNA pathway and the communication between the siRNA pathway and others 
could play an important role. Therefore, in this study, we described the Vago orthologue in bumblebees of Bombus 
terrestris, and then investigated its role as a possible communication gene between the siRNA pathway and JAK/
STAT pathway. B. terrestris is one of the most numerous bumblebee species in Europe and important for the polli-
nation of wild flowers and also many crops in agriculture. The study of immunity in bees is different from studies 
in model insects like Drosophila and mosquito. Indeed different bees, ranging from solitary to social bees, all have 
a rather small immune genes repertoire12,28,29. This lower immune repertoire in bees, with a different degree of 
sociality, indicates the evolution of bee immunity predates the evolution of sociality12,28. Here, we used B. terrestris 
as a model for a primary social insect to see how they respond to different viral infections, specifically IAPV as 
virulent infection and SBPV as avirulent infection.
Results
The orthologue of Vago in B. terrestris. From the genome of B. terrestris, a protein sequence of 153-aa 
presenting the similar character with CxVago (Vago of Culex quinquefasciatus: XP_ 001842264.1) was obtained. 
This protein sequence showed eight conserved cysteine residues which form a von Willebrand factor C-domain 
(VWC) (Supplementary file: Figure S1). Phylogenetic analysis of Vago-related protein sequences revealed that 
insect Vago mainly followed the taxonomy (Fig. 1), indicating that this protein sequence obtained from B. terres-
tris was closely related with honeybee Vago. Based on the VWC domain as a template from Protein Data Bank 
(PDB code 1U5M), the 3D protein structure of BtVago and CxVago were constructed by Swiss-model (http://
swissmodel.expasy.org/interactive accessed on: April 22, 2015), while only seven conserved cysteine residues of 
each Vago were alignment with the 1U5M (Fig. 1). Therefore, this orthologue of Vago/Vago-like from B. terrestris 
was named as proposed BtVago (XP_003399812.1). SignalP 4.130 analysis of the BtVago amino acid sequence 
indicated a signal peptide cleavage site between amino acids 16 and 17 (Supplementary file: Figure S2). This sug-
gests that BtVago may also be secreted as described in mosquito to present an interferon-like antiviral function7,15. 
Since it is difficult to prove this functions in vivo and because of the lack of cell line of bumblebees at this moment, 
the biological evidence to prove that BtVago may also be secreted and to test the overexpression of BtVago in 
effecting viral titers, awaits further studies. In order to identify the possible promoter region responsible for 
BtVago activation, an ~2 kb upstream from the transcription start site in the 5′ regions was analyzed by PROMO. 
The results indicated the presence of a NF-κ B biding site in the BtVago promoter region (Supplementary file: 
Table S1).
BtVago was downregulated upon infection with IAPV but not SBPV. In silico analysis above pro-
vided some evidences of the presence of a functional BtVago, thus we wondered whether the viral infections, such 
as virulent (IAPV) and avirulent (SBPV) infections, could influence the expression of BtVago. Upon viral infec-
tion in mosquito, the siRNA pathway can induce the expression of Vago through a Dicer-2 dependent manner, 
which further lead to the activation of JAK-STAT pathway7,15. Therefore, we chose the time points with BtDicer-2 
upregulation induced by the infection of IAPV or SBPV based on our previous study24, to study the expression 
of BtVago. In contrast to mosquito and honeybee showing an upregulation of Vago upon viral infections7,15,31, 
our results (Fig. 2A,B) showed that the expression of BtVago was downregulated upon the infection of IAPV 
(both inoculation ways: injection (t-test: t = − 3.773, df = 8.5, p = 0.005) and ingestion (t-test: t = 2.211, df = 14, 
p = 0.044) when the expression of BtDicer-2 was significantly upregulated with the IAPV infection. Conversely, 
the expression of BtVago was not changed upon the infection of SBPV when the expression of BtDicer-2 was 
significantly upregulated (Fig. 2C).
Silencing of BtVago downregulated BtDicer-2 expression upon IAPV infection but downregu-
lated BtHop expression upon SBPV infection. Next, we wondered whether the depletion of BtDicer-2 
or BtVago could interfere with each other’s expression upon the stress of viral infections. The results showed 
that the silencing of BtDicer-2 upon both viral infections did not influence the expression of BtVago and BtHop 
(Fig. 3A,C). Indeed, in a RNAi-of-RNAi experiment, the pre-silencing of BtDicer-2 impacted the later-silencing 
of peptidylprolyl isomerase A (PPIA) suggesting that this minor drop had functional implication (Niu et al., 
2016), thus the non-detection of an effect on BtVago and BtHop to virus is probably not a consequence of the 
somewhat low silencing efficiency of RNAi24. The silencing of BtVago upon IAPV but not SBPV infection signif-
icantly decreased the expression of BtDicer-2 (t-test: t = 4.009, df = 17.3, p = 0.001) (Fig. 3B), while the silencing 
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of BtVago upon SBPV but not IAPV infection showed a significant downregulation of BtHop (t-test: t = 2.153, 
df = 18, p = 0.045) (Fig. 3D). In the bumblebees without SBPV or IAPV infection, the silencing of BtDicer-2 or 
BtVago showed no effect to each other’s expression. Additionally, the silencing of BtVago presented a downreg-
ulation of BtHop, again suggesting an association between BtVago and JAK/STAT pathway (Supplementary file: 
Figure S3). In summary, these results indicated that the disruption of BtVago translation may interfere with the 
expression of BtDicer-2 upon IAPV infection or the expression of BtHop upon SBPV infection, respectively.
Silencing of BtVago did not influence IAPV and SBPV genome copy numbers. To further explore 
the possible role of BtVago during viral infections, we measured the amount of viral genome copy numbers after 
the silencing of BtVago. The amounts of IAPV showed no differences between treatments with dsGFP (n = 15) 
and dsVago (n = 9) (Fig. 4A). The amount of SBPV genome copy numbers also stayed constant between treat-
ments dsGFP (n = 20) and dsVago (n = 16) (Fig. 4B).
Silencing of BtHop temporarily increased the genome copy numbers of SBPV. To identify the 
involvement of the JAK/STAT pathway upon virus infections, we looked whether the silencing of BtHop could 
influence viral infections (Fig. 5). We detected the viral genome copy numbers upon the silencing of BtHop. The 
results revealed that the silencing of BtHop did not influence the amount of IAPV genome copy numbers com-
pared with the dsGFP control (Fig. 5A). However, it significantly increased the amount of genome copy numbers 
of SBPV at two days post injection (dpi) but not at three dpi (t-test: t = − 2.683, df = 19, p = 0.015) (Fig. 5B). These 
results suggest that the JAK/STAT pathway plays a role against SBPV infection.
Discussion
Dicer-2 belongs to the same DExD/H-box helicase family as the RIG-I-like receptors, which sense viral infection 
and mediate interferon induction in mammals32. The induction of core genes, especially Dicer-2, in the siRNA 
pathway by viral infection is detected in the honeybee33 and the bumblebee24. Studies from Drosophila and mos-
quito showed that Vago could be induced in a Dicer-2-dependent manner upon viral infection7,15,32. Conversely, 
in the current study, we observed that IAPV infection increased the expression of BtDicer-2, while the expres-
sion of BtVago was reduced. To the best of our knowledge, this is the first time to report the downregulation of 
Figure 1.  Phylogenetic analysis of Vago-like protein sequences and proposed 3D structures of BtVago 
and CqVago based on 1U5M. MEGA 6.037, was used to construct the phylogenetic tree of Vago-like proteins 
through Maximun Likelihood. The conserved amino acids from chosen sequences of each species were used 
(Supplementary file: S1). The number of Bootstrap replications was 500 to test the phylogeny. The model of 
LG + G was adapted according to the model test of all input sequences. The proposed protein 3D structures of 
Culex quinquefasciatus Vago and Bombus terrestris Vago-like proteins, was constructed based by SWIS-MODEL 
through the template from Protein Data Bank (PDB code 1U5M). The amino acids in red shows conserved 
cysteine residues of each Vago were alignment with the 1U5M during the model constructions.
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Vago/Vago-like in insects upon viral infection. The downregulation of BtVago seems linked with IAPV rather than 
with Dicer-2 since the infection of SBPV resulted in only the upregulation of BtDicer-2 but no change of BtVago. 
In Drosophila, Vago is induced after viral infections, such as DCV and Sindbis virus, but not from flock house 
virus32. All these evidences suggest that the expression of Vago (up, down, or constant) may be “case by case” 
dependent on the context of virus species and/or virus–host interactions.
Vago appears to be a cytokine that acts in a similar manner with mammalian interferon to induce the antiviral 
activity of the JAK/STAT pathway in neighboring cells7,15. The silencing of CqHop, but not CqDome, influenced 
the CqVago-induced suppression of WNV replication through the JAK/STAT pathway7. Thus, we tried to inves-
tigate whether BtVago played a role in the communication between the siRNA and JAK/STAT pathways upon 
infection with IAPV and SBPV. In our study, with the silencing of BtVago, it showed a reduced expression of 
BtDicer-2, but not BtHop, upon the infection of IAPV. Conversely, there was a reduced expression of BtHop, 
but not BtDicer-2, upon the infection of SBPV. These results indicate that the described association of Vago with 
JAK/STAT was noticed in bumblebees upon the infection of the avirulent virus SBPV. However, this association 
could not be proven when bees were infected with the virulent virus IAPV. To further verify the biological context 
of the downregulation of Vago to viral infections, we silenced BtVago to detect its impact on IAPV and SBPV 
infections. In contrast to our expectations it did not show any influence on virus genome copy numbers for both 
viruses. However, in other studies, the silencing of Vago or the mutation of Vago could lead to an increase of virus 
titers7,32. Nevertheless, in our experimental setup, it could indeed miss the correct time-points or sampling tissues 
(the lacking of information about viral titters in tissues rather than the whole body) to see the expected effect of 
the associations between RNAi (BtDicer-2) and JAK/STAT (BtHop) through BtVago upon infections of IAPV and 
SBPV in bumblebees. Thus, further studies are needed to elucidate more details on this aspect.
Considering that the JAK/STAT pathway in insects could be triggered by two ways, in a direct and or indirect 
(e.g. Vago) manner upon viral infection7–9, it is important to understand the role of this pathway upon different viral 
infections, especially, virulent and avirulent viruses. When we silenced BtHop we observed an increased genome copy 
number of SBPV at 2 dpi. The involvement of this pathway in IAPV infection is less clear since the same approach failed 
to detect any influence on IAPV genome copy numbers. IAPV exhibited an extremely virulent infection in the current 
setup; thus a temporally silencing of BtHop may not provide a significant effect on the influence of IAPV genome copy 
numbers if the JAK/STAT pathway is involved in combating against IAPV infection in bumblebee.
Taken all above evidences together, the role of BtVago may be different upon infection with the virulent virus 
IAPV and the avirulent virus SBPV. Indeed, we formulated speculation on the role of BtVago upon the infection 
with different types of viruses. One, in the case that the infection is under control by the host (i.e. the bees do not 
die from SBPV) BtVago may act in a similar manner as the described cross-talk bridge between the siRNA and 
the JAK/STAT pathways in mosquito7,15. Conversely, we also observed that the so-called cross-talk role of BtVago 
may be different upon the virulent virus infection (IAPV).
An important question to consider is whether this downregulation of BtVago upon IAPV infection is of inter-
est to the host or/and the virus. On the one hand, it could be beneficiary to the virus via partially shutting off the 
BtVago communication between the siRNA and JAK/STAT pathways. On the other hand, it could also be benefi-
ciary to the host because switching off the induction of the extra activities of JAK/STAT triggered by Vago may be 
Figure 2. Fold changes of BtDicer-2, BtVago, and BtHop upon viral infections in comparison with controls 
(PBS). (A) IAPV infection was inoculated by injection. Two days after IAPV injection, the RNA samples were 
collected for gene expression analysis, PBS injected samples were collected as control. (B) IAPV infection was 
inoculated by ingestion (feeding). Five days after IAPV ingestion, the RNA samples were collected for gene 
expression analysis, PBS ingested samples were collected as control. (C) SBPV infection was inoculated by 
injection. Three days after SBPV injection, the RNA samples were collected for gene expression analysis, PBS 
injected samples were collected as control. Each treatment included eight biological replicates. The fold changes 
were equal to division of relative expression of each gene in virus infected samples by relative expression of the 
very gene in control samples. The relative expression of each gene was calculated based on internal reference 
gene PPIA. Each bar errors was represented by standard error of mean. The asterisk (*) represent statistical 
significant difference of mean (p < 0.05).
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able to open opportunities for other antiviral pathways. For instance, the activation of CqVago requires Relish215 
which is one of the components in the Imd antiviral pathway34. The downregulation of Vago could possibly be 
related with the increase of the activity of Imd in controlling viruses.
In conclusion, this project indicated that the possible role of Vago/Vago-like may vary between the infection 
with virulent (IAPV) and avirulent (SBPV) viruses in bumblebees. Upon SBPV infection, we see no effect on 
BtVago expression, but find evidence for the proposed interaction between Vago and the JAK/STAT pathway 
which could play a role in tempering SBPV infections. While upon IAPV infection, BtVago was down-regulated, 
potentially related with high virulence of this virus. Further studies are required to analyze this proposed role of 
Vago/Vago-like in viral virulence and in its association with antiviral immunities in bees.
Methods
Insects and viruses. Newly emerged workers were collected from the colonies of B. terrestris provided by 
Biobest NV (Belgium), and kept in micro-colonies fed with pollen and sugar water ad libitum in incubator under 
the condition of 29–31 °C, 60–65% relative humidity, and continuous darkness, for further experiments. Two 
bee viruses were chosen in this study based on their virulence in bumblebees: IAPV (virulent virus) presents 
an extremely fast replication and causes high mortalities of the bees within few days; SBPV (avirulent virus), its 
Figure 3. Fold changes of BtDicer-2, BtVago, and BtHop upon viral infections with pre-silencing of 
BtDicer-2 or BtVago in comparison with controls. (A) IAPV infection with BtDicer-2 pre-silencing. DsDicer2 
was injected to silence BtDicer-2, two days later, IAPV was injected to inoculate bees. Subsequently, RNA was 
collected post 1.5 days injection of IAPV for measuring gene expressions (n = 18). (B) IAPV infection with 
BtVago pre-silencing. DsVago was injected to silence BtVago, two days later, IAPV was injected to inoculate 
bees. Subsequently, RNA was collected post 1.5 days injection of IAPV for measuring gene expressions (n = 9). 
(C) SBPV infection with BtDicer-2 pre-silencing. DsDicer2 was injected to silence BtDicer-2, two days later, 
SBPV was injected to inoculate bees. Subsequently, RNA was collected post two days injection of SBPV for 
measuring gene expressions (n = 8). (D) SBPV infection with BtVago pre-silencing. DsVago was injected to 
silence BtVago, two days later, SBPV was injected to inoculate bees. Subsequently, RNA was collected post two 
days injection of SBPV for measuring gene expressions (n = 15). We used dsGFP and PBS injections as controls 
for dsRNA and viral injections, respectively, for each treatment. The fold changes were equal to division of 
relative expression of each gene in samples of viral infections and pre-gene silencing by relative expression of 
the very gene in control samples. The relative expression of each gene was calculated based on internal reference 
gene PPIA. Each bar errors was represented by standard error of mean. The asterisk (*) represent statistical 
significant difference of mean (p < 0.05).
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infection causing no mortality, replicates fast but slower compared to IAPV24. Colonies used in this study were 
screened to be free of IAPV and SBPV infections. In detail, ten bees from each colony were randomly collected 
Figure 4. Genome copy numbers of viruses upon silencing of BtVago. (A) IAPV: DsVago (n = 9) was 
injected to silence BtVago, two days after injection, IAPV was injected to inoculate bees. Subsequently, RNA 
was collected post 1.5 days injection of IAPV for measuring viral genome copy number. DsGFP injection was 
included as control (n = 15). (B) SBPV: DsVago (n = 16) was injected to silence BtVago, two days after injection, 
SBPV was injected to inoculate bees. Subsequently, RNA was collected post two days injection of SBPV for 
measuring viral genome copy number. DsGFP injection was included as control (n = 20). The means of each 
genome copy number were represented based on Log10 transformation and each bar errors were represented by 
standard error of mean. Different letters represent statistical significant difference of mean (p < 0.05).
Figure 5. Genome copy numbers of viruses upon silencing of core JAK/STAT pathway gene: BtHop. 
(A) IAPV: The injection of IAPV causes extremely high and fast mortality, therefore, we used feeding as the 
inoculation method. IAPV was firstly ingested by fixed age adult bees, and then after five days later, dsRNA 
were injected to silence BtHop. DsGFP and ES (Elution buffer) were included as the controls. Subsequently, 
post four days injection of dsRNA, genome copy number of IAPV was measured. (B) SBPV: dsRNA were firstly 
injected to silence BtHop in age fixed adult bees. After two days later, we injected SBPV to infect bumblebees. 
Subsequently, post two and three days injection of dsRNA, genome copy number of SBPV was measured. At 
least 8 biological replicates were included in each treatment. The means of each genome copy number were 
represented based on Log10 transformation and each bar errors were represented by standard error of mean. 
Different letters represent statistical significant difference of mean (p < 0.05).
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and checked for the infection status of IAPV and SBPV by RT-PCR (Supplementary file: Table S2). The infection 
status of other common bee viruses (except IAPV and SBPV) in the bees used in this study was not clear, which 
needs to be pointed out since it could possibly influence the overall antiviral immunity of hosts.
IAPV and SBPV inocula were produced by propagating virus reference isolates in 50 white-eyed honeybee 
pupae and preparing a chloroform-clarified extract in PBS (10 mM phosphate buffer (pH 7.0)/0.02% diethyl 
dithiocarbamate) by following the protocol described in a previous study35. The contamination of other common 
bee viruses in these inocula, such as acute bee paralysis virus, Kashmir bee virus, SBPV or IAPV, Chronic bee 
paralysis virus, DWV, Varroa destructor virus-1, sacbrood virus and black queen cell virus, were determined by 
RT-qPCR and was less than 0.1%. The genome copy number of the IAPV and SBPV inocula used in this study 
were 2.34 × 1010 and 4.5 × 1011 per μ l, respectively. To further analyze the number of viral particles, the inoc-
ula were measured through transmission electron microscopy with a standard protocol for negative staining by 
CODA-CERVA (Brussels, Belgium). The estimated number of particles were 1 × 106 for both IAPV and SBPV 
inocula. The genome copy number of virus represent all the mRNA associated with virus, which could be virus 
expressed mRNAs or viral genome, while TEM is focused on viral particles (capsid). In addition to the difference 
in detection sensitivity of qPCR and TEM, the estimation of viral concentration from qPCR is normally higher 
than that from TEM.
Viral inoculations. Bees were transferred into 50 ml tube and incubated on ice for ~20 min. Then, the uncon-
scious bees were immediately injected with virus by the nano-injector. For IAPV injection, we used ~20 particles 
(in 5 μ l solution) per bee and the amount of SBPV was ~200,000 particles (in 5 μ l solution) per bee. PBS injected 
bees served as control. To maintain an accurate injection and avoid any leak of injection solutions, we chose the 
soft white-like cuticle between the 1st and 2nd segments as injection site and the injection process were strictly 
screened under microscope. The injected bees were immediately transferred back to micro-colonies with the 
same condition as described before. When IAPV feeding was required, bees with 5 hours starvation were trans-
ferred into a petri dish, and a liquid drop (in 20 μ l solution) containing of an amount of 108 particles (mixed with 
sugar water instantly before feeding) were ingested per bee. Only bees that directly and completely ingested the 
solution within one hour were put back to micro-colonies. The control treatment was followed with the same 
procedure but with PBS spiked sugar water.
Gene silencing by dsRNA. A fragment of target gene was amplified by PCR with gene sequence specific 
primer plus T7 promoters (Supplementary file: Table S2). Then, these partial DNA templates of each gene were 
purified by E.Z.N.A. Cycle-Pure Kit (Omega, USA). The specificity of each template was checked by running 
the PCR products in an electrophoresis on 1.5% agarose gel and sequence confirmations for these templates 
(LGC genomics, Germany). Next, one microgram templates were used to synthesis dsRNA according to the 
guideline of MEGAscript RNAi Kit (Invitrogen, USA). The concentration and quality of each dsRNA were veri-
fied by Nanodrop and electrophoresis on 1.5% agarose gel. With the same procedure, a partial of GFP sequence 
(Supplementary file: S2) was used as template to synthesis dsGFP as negative control. For each gene silencing, a 
total of 20 μ g (in a volume of 20 μ l) of dsRNA were injected per bee, and same dose of dsGFP served as negative 
control for the effect of non-specific dsRNA. The injection of BtDicer-2, BtVago, and BtHop specific dsRNA 
showed a depletion of 59.6%, 67.6%, and 60.6% of its expression, respectively (Supplementary data, Figure S4).
Sample preparation for exploring the possible role of BtVago. Samples with viral infections. Two 
days after injection of IAPV, the whole body of the bee was collected for RNA extraction (n = 10), the bees 
injected with PBS undergoing the same procedure (n = 10) was used as control. For IAPV infection through feed-
ing, we collected bees after 9 days after IAPV feeding. The abdomen of each individual (n = 8) was used to extract 
RNA. PBS fed bees (n = 8) were used as controls. For SBPV, after 3 days injection, the abdomen of each bee was 
used for RNA isolation (n = 8), and the same treatment of PBS injection was used as control (n = 8). These time 
points used for viral inoculations or sample collections were based on the difference of viral virulence and viral 
titer dynamics24. The whole experiment was repeated twice.
Samples with silencing of BtVago or BtDicer-2 and viral infections. We first silenced the genes through injection 
of the sequence specific dsRNA, after two days, we inoculated bees with SBPV or IAPV by injection. Subsequently, 
post two days of SBPV injection and post 1.5 days IAPV infection, RNA for each group were collected. For group 
of SBPV, two treatments were applied, dsDicer-2-SBPV (n = 8) and dsVago-SBPV (n = 15). For groups of IAPV, 
two groups were involved: dsDicer-2-IAPV (n = 18) and dsVago-IAPV (n = 9). In each treatment, dsGFP controls 
were applied as the controls, respectively. These time points used for viral inoculations or sample collections were 
based on the difference of viral virulence and viral titer dynamics24. The whole experiment was repeated twice.
Detection of viral genome copy number. To measure whether the silencing of BtHop and BtVago 
could influence the amount of IAPV and SBPV genome copy number, the relative viral genome copy numbers 
in each sample were evaluated based on the standard curves calculated by qPCR in previous study24: with cq 
values (x) and corresponding genome copy number (y: log10), for IAPV, the equation is y = − 0.3017x + 8.8995 
(R2 = 0.9997); for SBPV, the equation is y = − 0.2926x + 9.4426 (R2 = 0.9996). The normalized genome copy num-
ber of each sample was represented by the ratio of the genome copy number calculated through the DNA stand-
ard curve and the normalization factor from the internal reference gene PPIA35.
RNA isolation, cDNA, and qPCR. RNA isolations were applied by RNeasy Mini Kit (Qiagen, Germany) 
according to manufactures’ instruction with a small modification in sample collection. In detail, 1.5~2 ml RLT 
buffer were used to homogenize the lysed bumblebee tissues by mortar and the supernatants were centrifuged 
for three times to remove the tissue-debris pellet. Afterwards the steps were followed by the standard protocol 
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of the kit. Genomic DNA was removed by treatment with TURBO DNA-free Kit (Ambion, USA). RNA quantity 
and quality were checked by Nanodrop and electrophoresis on 1.5% agarose gel. Two micrograms of RNA were 
used to synthesize the cDNA in a volume of 20 μ l by SuperScript II Reverse Transcriptase (Invitrogen, USA) using 
oligo (dT) primers. To confirm that genomic DNA was completely removed we checked cDNA samples with 
exon spanning primers for RPL23 (Supplementary data Table S2). The cDNA should produce an amplicon of 
143 bp while possible genomic DNA contamination would produce an extra amplicon of 452 bp. The qPCR was 
performed in a volume of 20 μ l on a CFX96 Real-Time PCR Detection System (BioRad, USA) using GoTaq qPCR 
Master (Promega, USA). Each reaction was performed in duplicate and consisted of 10 μ l of GoTaq qPCR Master 
mix, 1 μ l of each primer (forward and reverse), and 8 μ l of cDNA (from 100 times dilution of cDNA synthesized 
above). A delta Cq of less than 0.5 was applied for duplicates to pass the quality control. Few samples failed and 
were re-analyzed in duplicate following the same criteria. The amplification specificity of primers was checked 
by both electrophoresis of the RT-PCR products and analysis of the dissociation curve of qPCR. In addition, 
RT-PCR products amplified by these primers were sequenced in order to confirm their primers’ specificities.
Data analysis. The data transformation and normalization of gene expression was followed as the framework 
of qBase36. First, relative quantities for each gene in each sample by comparing the Cq of a given sample with the 
average Cq across all samples for that gene was calculated, with taking into account of the amplification efficiency 
of that gene; next, the relative quantities of that gene was normalized by the relative quantities of the optimal 
reference gene (PPIA)35; finally, the relative expression of each gene was rescaled to the average expression level 
across all samples. The normality of all the data sets was tested by Shapiro-Wilk, then the mean comparisons of 
gene expressions and viral genome copy number (log10 transformed) were separated by independent samples 
t-test (for data sets that passed the normality test) or Mann-Whitney U test (for data sets that failed to pass the 
normality test) by SPSS statistics 22. Additionally, both t-test and Mann-Whitney U test were used for all the data 
sets to increase the power of the tests, while both tests showed consistent results of the significant level with each 
other. A significant level was indicated as p < 0.05.
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